Ferocure CV 325 is a combination antibiotic designed to provide broad-spectrum coverage, including infections caused by beta-lactamase–producing bacteria. It ensures improved efficacy and faster recovery in moderate to severe bacterial infections.
Manufactured under strict quality standards, Ferocure CV 325 offers reliable performance and better patient outcomes in clinical practice.
Enhanced antibacterial action for better infection control
Broad-spectrum antibacterial activity
Effective against resistant (beta-lactamase–producing) bacteria
Helps achieve faster and more reliable infection control
Suitable for a wide range of bacterial infections
Well tolerated with a good safety profile
Cefixime: Third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis.
Potassium Clavulanate: Beta-lactamase inhibitor that protects cefixime from degradation and enhances its effectiveness.
Ferocure CV 325 is recommended for effective treatment of moderate to severe bacterial infections with improved efficacy and reliable outcomes.